XML 41 R20.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Stockholders' Equity | 12 Months Ended
--- | ---
Dec. 31, 2019
Stockholders' Equity |
Stockholders' Equity | Note 11. Stockholders’ Equity Preferred Stock. We are authorized to issue 5,000,000 shares of preferred stock, none of which was outstanding as of December 31, 2019 and 2018. The Board of Directors may determine the rights, preferences and privileges of any preferred stock issued in the future. Common Stock. We are authorized to issue 400,000,000 shares of common stock. Stock Compensation Plans. As of December 31, 2019, we had a total of 10,336,053 shares of our common stock available for future issuance related to our stock plans as described below. 2010 Stock Incentive Plan. In May 2010 the Board of Directors adopted the 2010 Stock Incentive Plan, which was amended and restated in April 2013 and in March 2019 (the “2010 Plan”), for issuance of common stock to employees, non-employee directors, consultants, and scientific advisors. Options are granted to employees, consultants, and scientific advisors under the 2010 Plan, pursuant to a formula determined by our Board of Directors. All options are exercisable at the fair market value of the stock on the date of grant. Non-employee director options expire after ten years. In April 2019, our stockholders approved an increase in the number of shares of common stock reserved for issuance under the 2010 Plan from 36,753,475 to 44,453,475. Option activity under the 2010 Stock Plan was as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Shares Subject to | ​
​ | ​ | Outstanding Options | ​
​ | ​ | ​ | ​ | Weighted Average | ​
​ |  | Shares |  | Exercise Price |
Balance at December 31, 2018 |  | 12,285,159 | ​ | $ | 74.39 | ​
Options granted |  | 3,426,061 | ​ | $ | 76.60 | ​
Options exercised |  | (2,199,835) | ​ | $ | 30.68 | ​
Options cancelled | ​ | (878,728) | ​ | $ | 91.33 | ​
Balance at December 31, 2019 |  | 12,632,657 | ​ | $ | 81.42 | ​
​ In July 2016, we revised the terms of our annual stock option grants to provide that new option grants would generally have a 10-year term and vest over four years, with 25% vesting after one year and the remainder vesting in 36 equal monthly installments. Previously, our option grants generally had 7-year terms and vested over three years, with 33% vesting after one year and the remainder vesting in 24 equal monthly installments. Options to purchase a total of 6,896,492, 7,194,171 and 7,250,283 shares as of December 31, 2019, 2018 and 2017, respectively, were exercisable. The aggregate intrinsic value of options exercised for the years ended December 31, 2019, 2018 and 2017 were $113.8 million, $73.9 million and $264.2 million, respectively. At December 31, 2019 the aggregate intrinsic value of options outstanding and vested options are $162.5 million and $158.7 million, respectively. The following table summarizes information about stock options outstanding as of December 31, 2019 under the 2010 Plan: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Options Outstanding | ​ | Options Exercisable | ​
​ |  | ​ |  | Weighted Average |  | Weighted |  | ​ |  | Weighted | ​
​ | ​ | ​ | ​ | Remaining | ​ | Average | ​ | ​ | ​ | Average | ​
​ | ​ | Number | ​ | Contractual Life | ​ | Exercise | ​ | Number | ​ | Exercise | ​
Range of Exercise Prices | ​ | Outstanding | ​ | (in years) | ​ | Price | ​ | Exercisable | ​ | Price | ​
$13.34 - $61.75 |  | 1,273,143 |  | 1.77 | ​ | $ | 30.33 |  | 1,247,056 | ​ | $ | 29.67 | ​
$62.87 - $68.62 |  | 1,942,267 |  | 6.44 | ​ |  | 67.21 |  | 1,005,035 | ​ |  | 66.30 | ​
$68.82 - $68.97 |  | 59,644 |  | 8.84 | ​ |  | 68.95 |  | 15,913 | ​ |  | 68.95 | ​
$72.27 - $72.27 |  | 1,929,341 |  | 8.97 | ​ |  | 72.27 |  | 426,451 | ​ |  | 72.27 | ​
$72.58 - $81.60 |  | 1,267,721 |  | 4.52 | ​ |  | 74.76 |  | 938,974 | ​ |  | 73.70 | ​
$83.58 - $85.01 |  | 1,627,376 |  | 8.02 | ​ |  | 84.50 |  | 651,669 | ​ |  | 83.97 | ​
$85.34 - $95.34 |  | 1,336,692 |  | 7.69 | ​ |  | 93.50 |  | 508,940 | ​ |  | 92.76 | ​
$95.54 - $113.64 | ​ | 2,263,583 | ​ | 5.49 | ​ | ​ | 105.46 | ​ | 1,470,017 | ​ | ​ | 104.02 | ​
$115.19 - $134.38 | ​ | 906,782 | ​ | 7.07 | ​ | ​ | 128.16 | ​ | 615,041 | ​ | ​ | 128.42 | ​
$138.52 - $138.52 | ​ | 26,108 | ​ | 7.25 | ​ | ​ | 138.52 | ​ | 17,396 | ​ | ​ | 138.52 | ​
​ |  | 12,632,657 | ​ | ​ | ​ | ​ | ​ |  | 6,896,492 | ​ | ​ | ​ | ​
​ Restricted Stock Units and Performance Shares In January 2014, we began granting RSUs and PSUs to our employees at the share price on the date of grant. Each RSU represents the right to acquire one share of our common stock. Each RSU granted prior to July 2016 was subject to cliff vesting after three years. In July 2016, we revised the terms of our RSU grants to provide that the awards will vest 25% annually over four years. Also, in January 2014, Hervé Hoppenot, our President and Chief Executive Officer, was granted a one-time grant of 400,000 RSUs outside of our 2010 Stock Incentive Plan. Vesting of the RSUs will be subject to Mr. Hoppenot’s continued employment on the applicable vesting dates, with one-sixth of the RSUs vesting at the end of each of the calendar years 2014 through 2019, subject to earlier acceleration of vesting upon the occurrence of certain events in accordance with the terms of his employment agreement. As of December 31, 2019, all of the RSUs granted to Mr. Hoppenot were vested. In June 2018, we granted 190,000 RSUs and 446,500 PSUs under long term incentive plans with performance and/or service-based milestones with graded and/or cliff vesting over three to four years. In April 2019, we granted an additional 100,000 PSUs under one of the existing long term incentive plans with performance based milestones and cliff vesting. For one of the existing long term incentive plans, under which 106,500 PSUs were granted, the actual number of shares of our common stock into which each PSU may convert was subject to a multiplier of up to 267% based on the level at which the performance conditions were achieved. The actual number of shares of our common stock into which each PSU will convert is at a multiplier of 142% based on the performance conditions being achieved as of March 31, 2019. For an existing long term incentive plan, under which 150,000 PSUs were granted, the actual number of shares of our common stock into which each PSU may convert was subject to a multiplier of up to 100% if all performance conditions were achieved or 0% if no performance conditions were achieved. The actual number of shares of our common stock into which each PSU will convert is at a multiplier of 100% based on the performance conditions being achieved as of December 31, 2019. Compensation expense for the performance-based awards is recorded over the estimated service period for each milestone when the performance conditions are deemed probable of achievement. For the year ended December 31, 2019, the stock compensation expense recorded during the period was for service-based awards and performance conditions deemed probable of achievement and/or achieved. For PSUs containing performance conditions which were not deemed probable of achievement at December 31, 2019, no stock compensation expense was recognized. In July 2018, we granted 77,243 PSUs to executives with a performance milestone and graded vesting over four years. The shares of our common stock into which each PSU may convert is subject to a multiplier up to 150% based on the level at which the performance condition is achieved. Compensation expense for the performance-based awards is recorded over the estimated service period when the performance condition is deemed probable of achievement. The actual number of shares of our common stock into which each PSU will convert is at a multiplier of 83% based on the performance condition being achieved as of December 31, 2018. In July 2019, we granted 86,975 PSUs to executives with a performance milestone and graded vesting over four years. The shares of our common stock into which each PSU may convert is subject to a multiplier up to 125% based on the level at which the performance condition is achieved. Compensation expense for the performance-based awards is recorded over the estimated service period when the performance condition is deemed probable of achievement. The actual number of shares of our common stock into which each PSU will convert is at a multiplier of 101.8% based on the performance condition being achieved as of December 31, 2019. RSU and PSU award activity under the 2010 Stock Plan was as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Shares Subject to | ​
​ | ​ | Outstanding Awards | ​
​ |  | Shares |  | Grant Date Value |
Balance at December 31, 2018 |  | 2,043,337 | ​ | $ | 80.35 | ​
RSUs granted | ​ | 1,154,361 | ​ | $ | 83.23 | ​
PSUs granted | ​ | 233,467 | ​ | $ | 79.37 | ​
RSUs released | ​ | (592,736) | ​ | $ | 87.70 | ​
PSUs released | ​ | (13,325) | ​ | $ | 68.62 | ​
RSUs cancelled | ​ | (184,214) | ​ | $ | 83.23 | ​
PSUs cancelled | ​ | (38,514) | ​ | $ | 66.16 | ​
Balance at December 31, 2019 | ​ | 2,602,376 | ​ | $ | 79.69 | ​
​ The following table summarizes our shares available for grant under the 2010 Plan: ​
​ | ​ | ​ | ​
​ | ​ | Shares Available | ​
​ |  | for Grant |
Balance at December 31, 2018 |  | 7,023,328 | ​
Additional authorization |  | 7,700,000 | ​
Options, RSUs and PSUs granted |  | (5,983,442) | ​
Options, RSUs and PSUs cancelled | ​ | 1,142,236 | ​
Balance at December 31, 2019 |  | 9,882,122 | ​
​ Employee Stock Purchase Plan. On May 21, 1997, our stockholders adopted the 1997 Employee Stock Purchase Plan (the “ESPP”). Each regular full-time and part-time employee working 20 hours or more per week is eligible to participate after one month of employment. We issued 239,590, 233,712 and 157,277 shares under the ESPP in 2019, 2018 and 2017, respectively. For the years ended December 31, 2019, 2018 and 2017, we recorded stock compensation expense of $3.4 million, $3.7 million and $3.2 million, respectively, as the ESPP is considered compensatory under the FASB stock compensation rules. As of December 31, 2019, 453,931 shares remain available for issuance under the ESPP.

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration